Your browser doesn't support javascript.
loading
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
de Groot, Stefanie; Pijl, Hanno; Charehbili, Ayoub; van de Ven, Saskia; Smit, Vincent T H B M; Meershoek-Klein Kranenbarg, Elma; Heijns, Joan B; van Warmerdam, Laurence J C; Kessels, Lonneke W; Dercksen, M Wouter; Pepels, Manon J A E; van Laarhoven, Hanneke W M; Vriens, Birgit E P J; Putter, Hein; Fiocco, Marta; Liefers, Gerrit-Jan; van der Hoeven, Jacobus J M; Nortier, Johan W R; Kroep, Judith R.
Afiliação
  • de Groot S; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
  • Pijl H; Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
  • Charehbili A; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
  • van de Ven S; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Smit VTHBM; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Meershoek-Klein Kranenbarg E; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Heijns JB; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • van Warmerdam LJC; Department of Medical Oncology, Amphia hospital, Breda, The Netherlands.
  • Kessels LW; Department of Clinical Oncology, Catharina Ziekenhuis, Eindhoven, The Netherlands.
  • Dercksen MW; Department of Medical Oncology, Deventer hospital, Deventer, The Netherlands.
  • Pepels MJAE; Department of Clinical Oncology, Maxima Medisch Centrum, Veldhoven, The Netherlands.
  • van Laarhoven HWM; Department of Clinical Oncology, Elkerliek Ziekenhuis, Helmond, The Netherlands.
  • Vriens BEPJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Putter H; Department of Clinical Oncology, Catharina Ziekenhuis, Eindhoven, The Netherlands.
  • Fiocco M; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Liefers GJ; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Hoeven JJM; Mathematical Department, Leiden University, Leiden, The Netherlands.
  • Nortier JWR; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Breast Cancer Res ; 21(1): 97, 2019 08 28.
Article em En | MEDLINE | ID: mdl-31455425
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Conservadores da Densidade Óssea / Ácido Zoledrônico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Conservadores da Densidade Óssea / Ácido Zoledrônico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda